Scorpius Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!About SCPX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees84
Employees84
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded2008
Founded2008
Employees84
Employees84
SCPX Key Statistics
Market cap18.02
Market cap18.02
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume13.08K
Average volume13.08K
High today$0.0001
High today$0.0001
Low today$0.0001
Low today$0.0001
Open price$0.0001
Open price$0.0001
Volume20.00
Volume20.00
52 Week high$146.00
52 Week high$146.00
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 18.02, Scorpius Holdings(SCPX) trades at $0.00. The stock has a price-to-earnings ratio of -0.02.
As of 2026-10-24, Scorpius Holdings(SCPX) stock has fluctuated between $0.00 and $0.00. The current price stands at $0.00, placing the stock 0.0% above today's low and 0.0% off the high.
The Scorpius Holdings(SCPX)'s current trading volume is 20, compared to an average daily volume of 13.08K.
During the past year, Scorpius Holdings(SCPX) stock moved between $0.00 at its lowest and $146.00 at its peak.
During the past year, Scorpius Holdings(SCPX) stock moved between $0.00 at its lowest and $146.00 at its peak.
People also own
Based on the portfolios of people who own SCPX. This list is generated using Robinhood data, and it’s not a recommendation.